Prevalences of autoimmune diseases in schizophrenia, bipolar I and II disorder, and controls

Psychiatry Research

Volumn 258, Issue , 2017, Pages 9-14

  Cremaschi, Laura ^a,b   Kardell, Mathias ^a   Johansson, Viktoria ^c   Isgren, Anniella ^a   Sellgren, Carl M ^d,e   Altamura, A Carlo ^b   Hultman, Christina M ^c   Landén, Mikael ^a,c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MILAN   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bipolar disorder; Epidemiology; Neuroimmunology; Schizophrenia

Indexed keywords

LITHIUM SALT;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SELF REPORT; STRUCTURED INTERVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; BIPOLAR DISORDER; MIDDLE AGED;

AUTOIMMUNE DISEASES; BIPOLAR DISORDER; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SCHIZOPHRENIA;

EID: 85030154740     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2017.09.071     Document Type: Article

References (67)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders DSM–IV–TR. 4th ed, 2000, American Psychiatric Association, Washington, DC (text rev).
2. Arias, I., Sorlozano, A., Villegas, E., de Dios Luna, J., McKenney, K., Cervilla, J., et al. Infectious agents associated with schizophrenia: a meta-analysis. Schizophr. Res. 136:1–3 (2012), 128–136.
3. Baethge, C., Blumentritt, H., Berghöfer, A., Bschor, T., Glenn, T., Adli, M., et al. Long-term lithium treatment and thyroid antibodies: a controlled study. J. Psychiatry Neurosci. 30:6 (2005), 423–427.
4. Bai, Y.M., Su, T.P., Chen, M.H., Chen, T.J., Chang, W.H., Risk of developing diabetes mellitus and hyperlipidemia among patients with bipolar disorder, major depressive disorder, and schizophrenia: a 10-year nationwide population-based prospective cohort study. J. Affect. Disord. 150:1 (2013), 57–62.
5. Benros, M.E., Eaton, W.W., Mortensen, P.B., The epidemiologic evidence linking autoimmune diseases and psychosis. Biol. Psychiatry 75:4 (2014), 300–306.
6. Benros, M.E., Nielsen, P.R., Nordentoft, M., Eaton, W.W., Dalton, S.O., Mortensen, P.B., Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am. J. Psychiatry 168:12 (2011), 1303–1310.
7. Benros, M.E., Pedersen, M.G., Rasmussen, H., Eaton, W.W., Nordentoft, M., Mortensen, P.B., A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis. Am. J. Psychiatry 171:2 (2014), 218–226.
8. Benros, M.E., Waltoft, B.L., Nordentoft, M., Ostergaard, S.D., Eaton, W.W., Krogh, J., et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry 70:8 (2013), 812–820.
9. Bergink, V., Gibney, S.M., Drexhage, H.A., Autoimmunity, inflammation, and psychosis: a search for peripheral markers. Biol. Psychiatry 75:4 (2014), 324–331.
10. Bocchetta, A., Loviselli, A., Lithium treatment and thyroid abnormalities. Clin. Pract. Epidemiol. Ment. Health, 2, 2006, 23.
11. Brey, R.L., Holliday, S.L., Saklad, A.R., Navarrete, M.G., Hermosillo-Romo, D., Stallworth, C.L., et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58:8 (2002), 1214–1220.
12. Brietzke, E., Kauer-Sant'Anna, M., Teixeira, A.L., Kapczinski, F., Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder. Brain Behav. Immun. 23:8 (2009), 1079–1082.
13. Chen, S.J., Chao, Y.L., Chen, C.Y., Chang, C.M., Wu, E.C., Wu, C.S., et al. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br. J. Psychiatry 200:5 (2012), 374–380.
14. Corvin, A., Morris, D.W., Genome-wide association studies: findings at the major histocompatibility complex locus in psychosis. Biol. Psychiatry 75:4 (2014), 276–283.
15. Dalman, C.H., Broms, J., Cullberg, J., Allebeck, P., Young cases of schizophrenia identified in a national inpatient register - Are the diagnoses valid?. Soc. Psychiatry Psychiatr. Epidemiol. 37:11 (2002), 527–531.
16. Danchenko, N., Satia, J.A., Anthony, M.S., Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15:5 (2006), 308–318.
17. DE Hert, M., Schreurs, V., Vancampfort, D., VAN Winkel, R., Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 8:1 (2009), 15–22.
18. Eaton, W.W., Hayward, C., Ram, R., Schizophrenia and rheumatoid arthritis: a review. Schizophr. Res. 6:3 (1992), 181–192.
19. Eaton, W.W., Byrne, M., Ewald, H., Mors, O., Chen, C.Y., Agerbo, E., et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 163:3 (2006), 521–528.
20. Eaton, W.W., Pedersen, M.G., Nielsen, P.R., Mortensen, P.B., Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord. 12:6 (2010), 638–646.
21. Emery, P., Solem, C., Majer, I., Cappelleri, J.C., Tarallo, M., A European chart review study on early rheumatoid arthritis treatment patterns, clinical outcomes, and healthcare utilization. Rheumatol. Int. 35:11 (2015), 1837–1849.
22. Finney, G.O., Juvenile onset diabetes and schizophrenia?. Lancet 2:8673 (1989), 1214–1215.
23. Forty, L., Ulanova, A., Jones, L., Jones, I., Gordon-Smith, K., Fraser, C., et al. Comorbid medical illness in bipolar disorder. Br. J. Psychiatry 205:6 (2014), 465–472.
24. Hartge, P., Participation in population studies. Epidemiology 17:3 (2006), 252–254.
25. Hsu, C.C., Chen, S.C., Liu, C.J., Lu, T., Shen, C.C., Hu, Y.W., et al. Rheumatoid arthritis and the risk of bipolar disorder: a nationwide population-based study. PLoS One, 9(9), 2014, e107512.
26. Hu, L.Y., Shen, C.C., Hu, Y.W., Chen, M.H., Tsai, C.F., Chiang, H.L., et al. Hyperthyroidism and risk for bipolar disorders: a nationwide population-based study. PLoS One, 8(8), 2013, e73057.
27. Isgren, A., Jakobsson, J., Pålsson, E., Ekman, C.J., Johansson, A.G., Sellgren, C., et al. Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment. Brain Behav. Immun. 43 (2015), 198–204.
28. Jakobsson, J., Bjerke, M., Sahebi, S., Isgren, A., Ekman, C.J., Sellgren, C., et al. Monocyte and microglial activation in patients with mood-stabilized bipolar disorder. J. Psychiatry Neurosci. 40:4 (2015), 250–258.
29. Johansson, V., Lundholm, C., Hillert, J., Masterman, T., Lichtenstein, P., Landén, M., et al. Multiple sclerosis and psychiatric disorders: comorbidity and sibling risk in a nationwide Swedish cohort. Mult. Scler. 20:14 (2014), 1881–1891.
30. Juvonen, H., Reunanen, A., Haukka, J., Muhonen, M., Suvisaari, J., Arajärvi, R., et al. Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus. Arch. Gen. Psychiatry 64:8 (2007), 894–899.
31. Karanti, A., Bobeck, C., Osterman, M., Kardell, M., Tidemalm, D., Runeson, B., et al. Gender differences in the treatment of patients with bipolar disorder: a study of 7354 patients. J. Affect. Disord. 174 (2015), 303–309.
32. Kayser, M.S., Dalmau, J., The emerging link between autoimmune disorders and neuropsychiatric disease. J. Neuropsychiatry Clin. Neurosci. 23:1 (2011), 90–97.
33. Kibirige, D., Luzinda, K., Ssekitoleko, R., Spectrum of lithium induced thyroid abnormalities: a current perspective. Thyroid Res., 6(1), 2013, 3.
34. Kraszewska, A., Chlopocka-wozniak, M., Abramowicz, M., Sowinski, J., Rybakowski, J.K., A cross-sectional study of thyroid function in 66 patients with bipolar disorder receiving lithium for 10–44 years. Bipolar Disord. 17:4 (2015), 375–380.
35. Kristjansson, E., Allebeck, P., Wistedt, B., Validity of the diagnosis of schizophrenia in a psychiatric inpatient register. Nord. Psykiatr. Tidsskr. 41 (1987), 229–234.
36. Kupka, R.W., Nolen, W.A., Post, R.M., McElroy, S.L., Altshuler, L.L., Denicoff, K.D., et al. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol. Psychiatry 51:4 (2002), 305–311.
37. Leucht, S., Burkard, T., Henderson, J., Maj, M., Sartorius, N., Physical illness and schizophrenia: a review of the literature. Acta Psychiatr. Scand. 116:5 (2007), 317–333.
38. Mager, D.R., Polymyalgia rheumatica: common disease, elusive diagnosis. Home Healthc. Now. 33:3 (2015), 132–136.
39. Miller, B.J., Buckley, P., Seabolt, W., Mellor, A., Kirkpatrick, B., Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 70:7 (2011), 663–671.
40. Modabbernia, A., Taslimi, S., Brietzke, E., Ashrafi, M., Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol. Psychiatry 74:1 (2013), 15–25.
41. Mors, O., Mortensen, P.B., Ewald, H., A population-based register study of the association between schizophrenia and rheumatoid arthritis. Schizophr. Res. 40:1 (1999), 67–74.
42. Morton, L.M., Cahill, J., Hartge, P., Reporting participation in epidemiologic studies: a survey of practice. Am. J. Epidemiol. 163:3 (2006), 197–203.
43. Najjar, S., Pearlman, D.M., Alper, K., Najjar, A., Devinsky, O., Neuroinflammation and psychiatric illness. J. Neuroinflamm., 10, 2013, 43.
44. Oken, R.J., Schulzer, M., At issue: schizophrenia and rheumatoid arthritis: the negative association revisited. Schizophr. Bull. 25:4 (1999), 625–638.
45. Pålsson, E., Jakobsson, J., Södersten, K., Fujita, Y., Sellgren, C., Ekman, C.J., et al. Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls. Eur. Neuropsychopharmacol. 25:4 (2015), 133–140.
46. Pego-Reigosa, J.M., Isenberg, D.A., Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease. Rheumatol. (Oxf.) 47:10 (2008), 1498–1502.
47. Pilkington, T.L., The coincidence of rheumatoid arthritis and schizophrenia. J. Nerv. Ment. Dis. 124:6 (1956), 604–606.
48. Poyraz, B.C., Aksoy, C., Balcioğlu, I., Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia. Eur. Neuropsychopharmacol. 18:9 (2008), 667–672.
49. Radhakrishnan, R., Calvin, S., Singh, J.K., Thomas, B., Srinivasan, K., Thyroid dysfunction in major psychiatric disorders in a hospital based sample. Indian J. Med. Res. 138:6 (2013), 888–893.
50. Rapaport, M.H., Schmidt, M.E., Risinger, R., Manji, H., The effects of prolonged lithium exposure on the immune system of normal control subjects: serial serum soluble interleukin-2 receptor and antithyroid antibody measurements. Biol. Psychiatry 35:10 (1994), 761–766.
51. Ripke, S., O'Dushlaine, C., Chambert, K., Moran, J.L., Kähler, A.K., Akterin, S., et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45:10 (2013), 1150–1159.
52. Rojo, L.E., Gaspar, P.A., Silva, H., Risco, L., Arena, P., Cubillos-Robles, K., et al. Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology. Pharmacol. Res. 101 (2015), 74–85.
53. Sasayama, D., Hattori, K., Wakabayashi, C., Teraishi, T., Hori, H., Ota, M., et al. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. J. Psychiatr. Res. 47:3 (2013), 401–406.
54. Sauvage, M.F., Marquet, P., Rousseau, A., Raby, C., Buxeraud, J., Lachâtre, G., Relationship between psychotropic drugs and thyroid function: a review. Toxicol. Appl. Pharmacol. 149:2 (1998), 127–135.
55. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium, Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43:10 (2011), 969–976.
56. Sellgren, C., Frisell, T., Lichtenstein, P., Landén, M., Askling, J., The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risks. Schizophr. Bull. 40:6 (2014), 1552–1559.
57. Simard, J.F., Sjöwall, C., Rönnblom, L., Jönsen, A., Svenungsson, E., Systemic lupus erythematosus prevalence in Sweden in 2010: what do national registers say?. Arthritis Care Res. (Hoboken) 66:11 (2014), 1710–1717.
58. Smith, D.J., Martin, D., McLean, G., Langan, J., Guthrie, B., Mercer, S.W., Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study. BMC Med., 11, 2013, 263.
59. Sperner-Unterweger, B., Fuchs, D., Schizophrenia and psychoneuroimmunology: an integrative view. Curr. Opin. Psychiatry 28:3 (2015), 201–206.
60. Streetman, D.D., Khanderia, U., Diagnosis and treatment of Graves disease. Ann. Pharmacother. 37:7–8 (2003), 1100–1109.
61. Stringer, S., Kahn, R.S., de Witte, L.D., Ophoff, R.A., Derks, E.M., Genetic liability for schizophrenia predicts risk of immune disorders. Schizophr. Res. 159:2–3 (2014), 347–352.
62. Stubbs, B., Vancampfort, D., De Hert, M., Mitchell, A.J., The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis. Acta Psychiatr. Scand. 132:2 (2015), 144–157.
63. Thomsen, A.F., Kvist, T.K., Andersen, P.K., Kessing, L.V., Increased risk of affective disorder following hospitalisation with hyperthyroidism - a register-based study. Eur. J. Endocrinol. 152:4 (2005), 535–543.
64. Torrey, E.F., Yolken, R.H., The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both?. Brain Behav. Immun. 15:4 (2001), 401–410.
65. Vanderpump, M.P., The epidemiology of thyroid disease. Br. Med. Bull. 99 (2011), 39–51.
66. Vinogradov, S., Gottesman, I.I., Moises, H.W., Nicol, S., Negative association between schizophrenia and rheumatoid arthritis. Schizophr. Bull. 17:4 (1991), 669–678.
67. Zetterberg, H., Jakobsson, J., Redsäter, M., Andreasson, U., Pålsson, E., Ekman, C.J., et al. Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment. Psychiatry Res. 217:3 (2014), 143–146.